Sunday 5 January 2014

Study affirms safety of HPV4 vaccine for adolescents and young women in routine clinical care

Study affirms safety of HPV4 vaccine for adolescents and young women in routine clinical care

A study of almost 200,000 young females who received the quadrivalent human papilloma virus vaccine found that immunization was associated only with same-day syncope and skin infections in the two weeks after vaccination. These findings support the general safety of routine vaccination with HPV4 in a clinical care setting to prevent cervical and other genital and reproductive cancers. read more..

No comments:

Post a Comment